Neurodesenvolvimento e intervenções terapêuticas em crianças com TDAH
DOI:
https://doi.org/10.36557/2674-8169.2024v6n8p4393-4399Keywords:
“Attention deficit hyperactivity disorder”; “ADHD in childhood”; “ADHD treatment”.Abstract
Attention Deficit Hyperactivity Disorder is a neurological condition characterized by signs of hyperactivity and inattention. The first symptoms appear in childhood and can persist into adulthood, compromising development and interpersonal relationships. In order to highlight the importance of early diagnosis and appropriate treatment to reduce its negative impacts, this study reviewed the literature available in the PubMed and ScieLO databases, with descriptors in English: “The Attention Deficit Disorder”; “ADHD in childhood” and “Prevalence of ADHD in children”. The diagnosis of the disorder is essentially clinical, based on DSM-5 and CID-11 criteria. For effective treatment, the use of medications is combined with non-pharmacological measures. Early diagnosis and appropriate treatment are essential to minimize the negative impacts of the disorder, promoting a better quality of life for individuals.
Downloads
References
ASSOCIAÇÃO AMERICANA DE PSIQUIÁTRICA. ASSOCIAÇÃO PSIQUIÁTRICA AMERICANA DSM-5 ®. [s.l: s.n.]. Disponível em: <https://www.institutopebioetica.com.br/documentos/manual-diagnostico-e-estatistico-de-transtornos-mentais-dsm-5.pdf>. 2. CAYE, A. et al. Estratégias de tratamento para o TDAH: um guia baseado em evidências para selecionar o tratamento ideal. Psiquiatria Molecular, v. 24, n. 3, p. 390–408, 1 de março. 2019. 3. DANCKAERTS, M. et al. A qualidade de vida de crianças com transtorno de déficit de atenção/hiperatividade: uma revisão sistemática. Psiquiatria Europeia da Criança e do Adolescente, v. 19, n. 2, p. 83–105, 1 de fevereiro. 2010. 4. DE FREITAS DE SOUSA, A. et al. TRANSTORNO DO DÉFICIT DE ATENÇÃO E HIPERATIVIDADE Edição 2020 Anthony de Freitas de Sousa. [s.l: s.n.]. Disponível em: <https://iacapap.org/_Resources/Persistent/69b849d851e040c48cc0036bf888874a4716afa3/D.1-ADHD-Portuguese-2020.pdf>. 5. GALVEZ-CONTRERAS, A. Y. et al. Abordagens Terapêuticas para TDAH por Estágio de Desenvolvimento e Apresentação Clínica. International Journal of Environmental Research and Public Health, v. 19, n. 19, p. 12880, 8 out. 2022.
ICD-11 for Mortality and Morbidity Statistics. Disponível em: <https://icd.who.int/browse/2024-01/mms/en#821852937>.
POLANCZYK, G. V. et al. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. International Journal of Epidemiology, v. 43, n. 2, p. 434–442, 24 jan. 2014.
JARA SEGURA, A. B. El TDAH, Trastorno por Déficit de Atención con Hiperactividad, en las clasificaciones diagnósticas actuales (C.I.E.10, D.S.M.IV–R y C.F.T.M.E.A.–R 2000). Norte de Salud Mental, v. 8, n. 35, p. 30–40, 2009.
NICE. Recommendations | Attention Deficit Hyperactivity disorder: Diagnosis and Management | Guidance | NICE. Disponível em: <https://www.nice.org.uk/guidance/ng87/chapter/Recommendations>.
ROCHA, N. S. et al. Association between sleep pattern and pharmacological treatment in children with attention deficit disorder with hyperactivity: a systematic review. Revista Paulista de Pediatria, v. 41, p. e2022065, 29 maio 2023.
. SHAW, M. et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Medicine, v. 10, n. 1, 4 set. 2012.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Leonardo José Soster, Bianca Bittarello Nichele, Pedro Wilson Borges de Santana, Amanda Naves Carvalho, Arthur Andrade Veludo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.
